TINA POLLEY: Open Payments
NPI 1548657117 · WOODBRIDGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,325 in 118 payments from 20 companies in 2025. Trend: 2023 $2,758 · 2024 $2,236 · 2025 $2,325
Food & beverage: $2,325
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $533 |
| Janssen Biotech, Inc. | 20 | $291 |
| QOL Medical, LLC | 8 | $210 |
| Madrigal Pharmaceuticals | 9 | $170 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $166 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $121 |
| PFIZER INC. | 5 | $117 |
| Lilly USA, LLC | 4 | $106 |
| Ipsen Biopharmaceuticals, Inc | 4 | $99 |
| GENZYME CORPORATION | 4 | $97 |
Products named: RINVOQ, TREMFYA, Sucraid, REZDIFFRA, DUPIXENT, IQIRVO, XIFAXAN, IBSRELA.
Industry payments across VA — which companies pay providers there.
